Matches in SemOpenAlex for { <https://semopenalex.org/work/W4286587514> ?p ?o ?g. }
- W4286587514 endingPage "8083" @default.
- W4286587514 startingPage "8083" @default.
- W4286587514 abstract "Hepatocellular carcinoma (HCC) incidence, as well as related mortality, has been steadily increasing in the USA and across the globe, partly due to the lack of effective therapeutic options for advanced HCC. Though sorafenib is considered standard-of-care for advanced HCC, it only improves median survival by a few months when compared to placebo. Sorafenib is also associated with several unpleasant side effects that often lead to early abatement of therapy. Here, we investigate whether a combination regimen including low-dose sorafenib and a non-toxic dose of anti-diabetic drug metformin can achieve effective inhibition of HCC. Indeed, combining metformin with low-dose sorafenib inhibited growth, proliferation, migration, and invasion potential of HCC cells. We observed a 5.3- and 1.9-fold increase in sub-G1 population in the combination treatment compared to sorafenib alone. We found that the combination of metformin enhanced the efficacy of sorafenib and inhibited the MAPK/ERK/Stat3 axis. Our in vivo studies corroborated the in vitro findings, and mice harboring HepG2-derived tumors showed effective tumor reduction upon treatment with low-dose sorafenib and metformin combination. This work sheds light on a therapeutic strategy aiming to augment sorafenib efficacy or dose-de-escalation that may prove beneficial in circumventing sorafenib resistance as well as minimizing related side effects." @default.
- W4286587514 created "2022-07-22" @default.
- W4286587514 creator A5008586835 @default.
- W4286587514 creator A5030200822 @default.
- W4286587514 creator A5035543524 @default.
- W4286587514 creator A5052188555 @default.
- W4286587514 creator A5059496981 @default.
- W4286587514 creator A5084624753 @default.
- W4286587514 date "2022-07-22" @default.
- W4286587514 modified "2023-09-30" @default.
- W4286587514 title "Metformin Enhances the Anti-Cancer Efficacy of Sorafenib via Suppressing MAPK/ERK/Stat3 Axis in Hepatocellular Carcinoma" @default.
- W4286587514 cites W1525305507 @default.
- W4286587514 cites W1533842935 @default.
- W4286587514 cites W1920952588 @default.
- W4286587514 cites W1947415419 @default.
- W4286587514 cites W1967349754 @default.
- W4286587514 cites W1971837077 @default.
- W4286587514 cites W1980520860 @default.
- W4286587514 cites W1987784827 @default.
- W4286587514 cites W1994193851 @default.
- W4286587514 cites W2012871356 @default.
- W4286587514 cites W2013827670 @default.
- W4286587514 cites W2029776483 @default.
- W4286587514 cites W2031368547 @default.
- W4286587514 cites W2032167210 @default.
- W4286587514 cites W2038897617 @default.
- W4286587514 cites W2053951934 @default.
- W4286587514 cites W2059251195 @default.
- W4286587514 cites W2061345986 @default.
- W4286587514 cites W2065455574 @default.
- W4286587514 cites W2077433243 @default.
- W4286587514 cites W2083200314 @default.
- W4286587514 cites W2084472730 @default.
- W4286587514 cites W2087021985 @default.
- W4286587514 cites W2095038055 @default.
- W4286587514 cites W2102414144 @default.
- W4286587514 cites W2111044696 @default.
- W4286587514 cites W2117701806 @default.
- W4286587514 cites W2146074838 @default.
- W4286587514 cites W2158373383 @default.
- W4286587514 cites W2168665897 @default.
- W4286587514 cites W2193852314 @default.
- W4286587514 cites W2227197023 @default.
- W4286587514 cites W2291726879 @default.
- W4286587514 cites W2341904425 @default.
- W4286587514 cites W2397590802 @default.
- W4286587514 cites W2492106461 @default.
- W4286587514 cites W2507610324 @default.
- W4286587514 cites W2522707923 @default.
- W4286587514 cites W2560154684 @default.
- W4286587514 cites W2576839195 @default.
- W4286587514 cites W2582878252 @default.
- W4286587514 cites W2619384557 @default.
- W4286587514 cites W2762942199 @default.
- W4286587514 cites W2775313944 @default.
- W4286587514 cites W2810381975 @default.
- W4286587514 cites W2888259312 @default.
- W4286587514 cites W2889008737 @default.
- W4286587514 cites W2898314774 @default.
- W4286587514 cites W2902532424 @default.
- W4286587514 cites W2903534691 @default.
- W4286587514 cites W2911009727 @default.
- W4286587514 cites W2926972066 @default.
- W4286587514 cites W2937977485 @default.
- W4286587514 cites W2941033601 @default.
- W4286587514 cites W2951202516 @default.
- W4286587514 cites W2955615964 @default.
- W4286587514 cites W2981216174 @default.
- W4286587514 cites W2989577306 @default.
- W4286587514 cites W2991283674 @default.
- W4286587514 cites W2994930425 @default.
- W4286587514 cites W3122230873 @default.
- W4286587514 cites W3128646645 @default.
- W4286587514 cites W3163736660 @default.
- W4286587514 cites W3195049043 @default.
- W4286587514 cites W4200553730 @default.
- W4286587514 cites W4205208754 @default.
- W4286587514 cites W4206841660 @default.
- W4286587514 cites W4245784696 @default.
- W4286587514 cites W4280541492 @default.
- W4286587514 cites W4281774590 @default.
- W4286587514 cites W4281981686 @default.
- W4286587514 cites W4283074078 @default.
- W4286587514 cites W4283204427 @default.
- W4286587514 cites W4283812631 @default.
- W4286587514 doi "https://doi.org/10.3390/ijms23158083" @default.
- W4286587514 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35897659" @default.
- W4286587514 hasPublicationYear "2022" @default.
- W4286587514 type Work @default.
- W4286587514 citedByCount "10" @default.
- W4286587514 countsByYear W42865875142022 @default.
- W4286587514 countsByYear W42865875142023 @default.
- W4286587514 crossrefType "journal-article" @default.
- W4286587514 hasAuthorship W4286587514A5008586835 @default.
- W4286587514 hasAuthorship W4286587514A5030200822 @default.
- W4286587514 hasAuthorship W4286587514A5035543524 @default.
- W4286587514 hasAuthorship W4286587514A5052188555 @default.
- W4286587514 hasAuthorship W4286587514A5059496981 @default.